Christopher Conn
Thousand Oaks, California, United States
2K followers
500+ connections
Activity
-
Was an honor moderating a session at Advancing Precision Medicine focused on the opportunities and challenges of Precision Medicine in non-Oncology…
Was an honor moderating a session at Advancing Precision Medicine focused on the opportunities and challenges of Precision Medicine in non-Oncology…
Liked by Christopher Conn
-
🔊 We’re excited to announce our upcoming New Frontiers seminar, Beyond ctDNA: Towards the Integration of Multi-omics and Multimodal AI in Liquid…
🔊 We’re excited to announce our upcoming New Frontiers seminar, Beyond ctDNA: Towards the Integration of Multi-omics and Multimodal AI in Liquid…
Liked by Christopher Conn
-
Exciting times for Amgen, especially the oncology portfolio!
Exciting times for Amgen, especially the oncology portfolio!
Liked by Christopher Conn
Experience
Education
Licenses & Certifications
-
Certificate in Regulatory Affairs: Medical Devices
Regulatory Affairs Professionals Society (RAPS)
Issued
Courses
-
Business Data Analysis - University of Massachusetts Amherst
-
-
Foundations of Accounting - University of Massachusetts Amherst
-
-
Foundations of Finance - University of Massachusetts Amherst
-
-
Influencing People - University of Michigan (Coursera)
-
-
Inspiring and Motivating Individuals - University of Michigan (Coursera)
-
-
Introduction to Marketing - University of Pennsylvania (Coursera)
-
-
Managing Talent - University of Michigan (Coursera)
-
Organizations
-
American Society of Clinical Oncology
-
-
Association for Molecular Pathology
-
-
Regulatory Affairs Professionals Society
-
More activity by Christopher
-
Analyzing pts with unresectable locally advanced #NSCLC on a phase 2 trial of short course consolidation immunotherapy after CRT, the authors found…
Analyzing pts with unresectable locally advanced #NSCLC on a phase 2 trial of short course consolidation immunotherapy after CRT, the authors found…
Liked by Christopher Conn
-
Our Executive Director, Lauren C. Leiman, will be speaking at the 3rd Annual Liquid Biopsy Surveillance Summit this November in Boston, MA! Lauren’s…
Our Executive Director, Lauren C. Leiman, will be speaking at the 3rd Annual Liquid Biopsy Surveillance Summit this November in Boston, MA! Lauren’s…
Liked by Christopher Conn
-
Every now and then an opportunity comes along to publish a review article at exactly the right time by exactly the right authors - I'm very excited…
Every now and then an opportunity comes along to publish a review article at exactly the right time by exactly the right authors - I'm very excited…
Liked by Christopher Conn
-
Lighting the night with the The Leukemia & Lymphoma Society supporting patients, survirors and those who have lost the battle. A cause that is near…
Lighting the night with the The Leukemia & Lymphoma Society supporting patients, survirors and those who have lost the battle. A cause that is near…
Liked by Christopher Conn
-
Persistence. Precision. Patients. An inspiring and energizing week at #Amgen South San Francisco #ASF. Great science is foundational to the success…
Persistence. Precision. Patients. An inspiring and energizing week at #Amgen South San Francisco #ASF. Great science is foundational to the success…
Liked by Christopher Conn
-
Think you know Amgen? 🎤 Follow Ben Chu as he puts our employees' knowledge to the test. #tinymic
Think you know Amgen? 🎤 Follow Ben Chu as he puts our employees' knowledge to the test. #tinymic
Liked by Christopher Conn
-
Join us and Precision Medicine Online next week for a live webinar on circulating tumor DNA (ctDNA) monitoring. Speakers will discuss ctDNA…
Join us and Precision Medicine Online next week for a live webinar on circulating tumor DNA (ctDNA) monitoring. Speakers will discuss ctDNA…
Liked by Christopher Conn
-
Thrilled this has finally hit the shelves after many a late night piecing this book together! Huge thanks to my amazing co-author @Beat Moeckli and…
Thrilled this has finally hit the shelves after many a late night piecing this book together! Huge thanks to my amazing co-author @Beat Moeckli and…
Liked by Christopher Conn
-
Wrapping up Mission Week at Amgen I feel extremely #grateful and #energized and with a renewed sense of purpose towards helping patients with unmet…
Wrapping up Mission Week at Amgen I feel extremely #grateful and #energized and with a renewed sense of purpose towards helping patients with unmet…
Liked by Christopher Conn
-
As many of you know I run ….a lot. My wife asks me why I get up at 4 AM...my friends think I’m crazy…colleagues simply shake their head. I would not…
As many of you know I run ….a lot. My wife asks me why I get up at 4 AM...my friends think I’m crazy…colleagues simply shake their head. I would not…
Liked by Christopher Conn
-
Robert Loberg Robert Loberg, currently the Vice President and Lifecycle Leader for Oncology & Genetics at Roche, brings a wealth of expertise to the…
Robert Loberg Robert Loberg, currently the Vice President and Lifecycle Leader for Oncology & Genetics at Roche, brings a wealth of expertise to the…
Liked by Christopher Conn
Other similar profiles
Explore more posts
-
Endeavor BioMedicines
#ICYMI: Last month we announced that we raised $132.5 million in an oversubscribed #SeriesC financing to advance our pipeline of potential therapies for fibrotic lung diseases and oncology. We are thankful for the support of our investors, board, #biotech community and the entire Endeavor BioMedicines team. In this BioSpace article, get more details about what this financing means for the future of our pipeline and our goal to restore hope for patients with life-threatening diseases: https://bit.ly/4aVqAmo #biotechnews #fundraising #venturecapital #oncology #lungdiseases
-
San Francisco Biotech Networks
SFBN Feed: Is pharma still fearful of the Inflation Reduction Act? https://lnkd.in/g5wiVXEN Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good summer morning! Today, we discuss the big Medicare price negotiations (and the not-entirely-meaningful [...] #BayArea #SanFrancisco #Biotech #Lifescience #News
-
The Jackson Laboratory
🎧 Check out the Mendelspod podcast episode, "Two Industry Leaders on Dealing with the Growing Complexity of Genomic Cancer Data," featuring JAX's Cara Statz & Illumina's Erica Schnettler discussing the landscape of oncology research, oncology testing and variant interpretation:
-
BioTalk Unzipped
What a great conversation we had today with Mark Arnold on location at American Association of Pharmaceutical Scientists (AAPS) | @aapscomms, PharmSci 360 in Salt Lake City! Great job, Joe Rajarao, PhD, MBA, Chad Briscoe, and Rebecca Stauffer! Thanks to all for their help in making this a success! Looking forward to releasing the Mark Arnold episodes on November 1st and 15th. #AAPS #pharmsci360 #biotechnology #pharmaceutical #science #podcast
-
Water Tower Research LLC
Check out Do Kim's latest industry report on the biopharma outlook for 2H24, where he examines the impact of the upcoming presidential election, drug pricing, obesity, I&I, cardiology, CNS and oncology drugs and M&A activity #IndustryAnalysis #Biopharma #Election #WTR #WaterTowerResearch
-
Lynx.MD
🌐 The Lynx.MD team is heading to San Diego for DIA 2024. Drug discovery is a complex, lengthy process. DIA brings together the life sciences community to discuss innovations accelerating advancements, bringing therapies to care faster. Reach out to the Lynx.MD team, including Collin Labar, on LinkedIn to learn more about how our partners are using Lynx.MD’s rich structured and unstructured data sets to find insights addressing medical affairs and market access. See you at #DIA2024! 🌟 #Data #Research
-
Medicilon Inc.
What an incredible day at the 22nd San Diego Biopharma Conference in the beautiful San Diego, full of thought leadership conversations. Dr. Qingcong Lin, president of Medicilon USA Corp., gave a wonderful presentation "Challenges of #ADC Preclinical #DMPK and Safety Evaluation" during the conference. #Medicilon specializes in ADC, a revolutionary approach to cancer treatment. Our services encompass the entire ADC development process, including: 🔹 ADC Chemistry: Payload and linker R&D, antibody-drug conjugation 🔹In Vitro Evaluation: Binding assays, internalization, cell cycle & apoptosis analysis, bystander effect studies 🔹In Vivo Evaluation: Pharmacodynamics, pharmacokinetics, toxicology studies Our team has successfully supported 28 #IND approvals for ADC therapies, underscoring our leadership in this field. 🔗Click to see more details: https://lnkd.in/dPc8mGSF #SABPA #Medicilon #Drugdiscovery #Preclinical
1 Comment
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Christopher Conn in United States
-
Christopher Conn
-
Christopher Conn
-
Christopher Conn
-
Christopher Conn
Principal at Conn Shaffer Consulting Engineers
106 others named Christopher Conn in United States are on LinkedIn
See others named Christopher Conn